These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 22151236)

  • 1. Donor-specific indirect pathway analysis reveals a B-cell-independent signature which reflects outcomes in kidney transplant recipients.
    Haynes LD; Jankowska-Gan E; Sheka A; Keller MR; Hernandez-Fuentes MP; Lechler RI; Seyfert-Margolis V; Turka LA; Newell KA; Burlingham WJ
    Am J Transplant; 2012 Mar; 12(3):640-8. PubMed ID: 22151236
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phenotypically and functionally distinct CD8+ lymphocyte populations in long-term drug-free tolerance and chronic rejection in human kidney graft recipients.
    Baeten D; Louis S; Braud C; Braudeau C; Ballet C; Moizant F; Pallier A; Giral M; Brouard S; Soulillou JP
    J Am Soc Nephrol; 2006 Jan; 17(1):294-304. PubMed ID: 16338967
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Renal Operational Tolerance Is Associated With a Defect of Blood Tfh Cells That Exhibit Impaired B Cell Help.
    Chenouard A; Chesneau M; Bui Nguyen L; Le Bot S; Cadoux M; Dugast E; Paul C; Malard-Castagnet S; Ville S; Guérif P; Soulillou JP; Degauque N; Danger R; Giral M; Brouard S
    Am J Transplant; 2017 Jun; 17(6):1490-1501. PubMed ID: 27888555
    [TBL] [Abstract][Full Text] [Related]  

  • 4. "Tip-toeing" to an assay for transplantation tolerance?
    Alegre ML; Chong AS
    Am J Transplant; 2012 Mar; 12(3):519-20. PubMed ID: 22151375
    [No Abstract]   [Full Text] [Related]  

  • 5. Enzyme-linked immunosorbent spot assay analysis of peripheral blood lymphocyte reactivity to donor HLA-DR peptides: potential novel assay for prediction of outcomes for renal transplant recipients.
    Najafian N; Salama AD; Fedoseyeva EV; Benichou G; Sayegh MH
    J Am Soc Nephrol; 2002 Jan; 13(1):252-259. PubMed ID: 11752045
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A case of acute antidonor antibody-mediated humoral rejection after renal transplantation with specific consideration of serial graft biopsy histology.
    Shimizu T; Tokiwa M; Yamaguchi Y
    Clin Transplant; 2002; 16 Suppl 8():62-7. PubMed ID: 12464135
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of immune regulation in transplant patients using the trans vivo delayed type hypersensitivity assay.
    Pelletier RP; Bickerstaff AA; Adams PW; Orosz CG
    Hum Immunol; 2007 Jun; 68(6):514-22. PubMed ID: 17509451
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Graft dysfunction in chronic antibody-mediated rejection correlates with B-cell-dependent indirect antidonor alloresponses and autocrine regulation of interferon-γ production by Th1 cells.
    Shiu KY; McLaughlin L; Rebollo-Mesa I; Zhao J; Burton H; Douthwaite H; Wilkinson H; Semik V; Dodd PC; Brookes P; Lechler RI; Hernandez-Fuentes MP; Kemper C; Dorling A
    Kidney Int; 2017 Feb; 91(2):477-492. PubMed ID: 27988211
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of a cross-platform biomarker signature to detect renal transplant tolerance in humans.
    Sagoo P; Perucha E; Sawitzki B; Tomiuk S; Stephens DA; Miqueu P; Chapman S; Craciun L; Sergeant R; Brouard S; Rovis F; Jimenez E; Ballow A; Giral M; Rebollo-Mesa I; Le Moine A; Braudeau C; Hilton R; Gerstmayer B; Bourcier K; Sharif A; Krajewska M; Lord GM; Roberts I; Goldman M; Wood KJ; Newell K; Seyfert-Margolis V; Warrens AN; Janssen U; Volk HD; Soulillou JP; Hernandez-Fuentes MP; Lechler RI
    J Clin Invest; 2010 Jun; 120(6):1848-61. PubMed ID: 20501943
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intragraft events preceding chronic renal allograft rejection in a modified tolerance protocol.
    Shimizu A; Yamada K; Sachs DH; Colvin RB
    Kidney Int; 2000 Dec; 58(6):2546-58. PubMed ID: 11115090
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transplant outcome of desensitized recipients after donor-specific transfusion.
    Okazaki H; Takahashi H; Oguma S; Jimbo M; Ishizaki M
    Transplant Proc; 1987 Feb; 19(1 Pt 1):750-2. PubMed ID: 3274863
    [No Abstract]   [Full Text] [Related]  

  • 12. Loss of tolerance to a maternal kidney transplant is selective for HLA class II: evidence from trans-vivo DTH and alloantibody analysis.
    Burlingham WJ; Jankowska-Gan E; VanBuskirk A; Orosz CG; Lee JH; Kusaka S
    Hum Immunol; 2000 Dec; 61(12):1395-402. PubMed ID: 11163098
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunosuppression Has Long-Lasting Effects on Circulating Follicular Regulatory T Cells in Kidney Transplant Recipients.
    Niu Q; Mendoza Rojas A; Dieterich M; Roelen DL; Clahsen-van Groningen MC; Wang L; van Gelder T; Hesselink DA; van Besouw NM; Baan CC
    Front Immunol; 2020; 11():1972. PubMed ID: 32983131
    [No Abstract]   [Full Text] [Related]  

  • 14. Efficacy of 2 Doses of Rituximab on B-Cell and Antidonor Antibody and Outcomes of ABO-Incompatible Living-Donor Pediatric Kidney Transplant.
    Hamasaki Y; Aikawa A; Itabashi Y; Muramatsu M; Hyoudou Y; Shinoda K; Takahashi Y; Sakurabayashi K; Mizutani T; Oguchi H; Kawamura T; Sakai K; Shishido S
    Exp Clin Transplant; 2019 Jan; 17(Suppl 1):105-109. PubMed ID: 30777532
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Postoperative production of anti-donor antibody and chronic rejection in renal transplantation.
    Abe M; Kawai T; Futatsuyama K; Tanabe K; Fuchinoue S; Teraoka S; Toma H; Ota K
    Transplantation; 1997 Jun; 63(11):1616-9. PubMed ID: 9197356
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chronic graft loss. Immunological and non-immunological factors.
    Hernandez-Fuentes MP; Lechler RI
    Contrib Nephrol; 2005; 146():54-64. PubMed ID: 15567920
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Matchmaking the B-cell signature of tolerance to regulatory B cells.
    Chong AS; Sciammas R
    Am J Transplant; 2011 Dec; 11(12):2555-60. PubMed ID: 21967001
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Abrogation of antibody-mediated allograft rejection by regulatory CD4 T cells with indirect allospecificity.
    Callaghan CJ; Rouhani FJ; Negus MC; Curry AJ; Bolton EM; Bradley JA; Pettigrew GJ
    J Immunol; 2007 Feb; 178(4):2221-8. PubMed ID: 17277127
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circulating alloreactive T cells correlate with graft function in longstanding renal transplant recipients.
    Bestard O; Nickel P; Cruzado JM; Schoenemann C; Boenisch O; Sefrin A; Grinyó JM; Volk HD; Reinke P
    J Am Soc Nephrol; 2008 Jul; 19(7):1419-29. PubMed ID: 18417724
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Individualised immunosuppression with intravenously administered donor-derived modified immune cells compared with standard of care in living donor kidney transplantation (TOL-2 Study): protocol for a multicentre, open-label, phase II, randomised controlled trial.
    Morath C; Schmitt A; Schmitt M; Wang L; Kleist C; Opelz G; Süsal C; Tran TH; Scherer S; Schwenger V; Kemmner S; Fischereder M; Stangl M; Hauser IA; Sommerer C; Nusshag C; Kälble F; Speer C; Benning L; Bischofs C; Sauer S; Schubert ML; Kunz A; Hückelhoven-Krauss A; Neuber B; Mehrabi A; Schwab C; Waldherr R; Sander A; Büsch C; Czock D; Böhmig GA; Reiser J; Roers A; Müller-Tidow C; Terness P; Zeier M; Daniel V; Schaier M
    BMJ Open; 2022 Nov; 12(11):e066128. PubMed ID: 36368749
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.